Combination mRNA/Keytruda Product Shows Efficacy in Melanoma

Results of a Merck/Moderna collaboration are the first evidence of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial, according to the companies.
Source: Drug Industry Daily